Ingestion of red wine significantly increases plasma phenolic acid concentrations but does not acutely affect ex vivo lipoprotein oxidizability

American Journal of Clinical Nutrition

Volumn 71, Issue 1, 2000, Pages 67-74

  Caccetta, Rima Abu Amsha ^a   Croft, Kevin D ^a,b   Beilin, Lawrence J ^a   Puddey, Ian B ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b Box X 2213 GPO   (Australia)

Author keywords

4 O methylgallic acid; Bioavailability; Caffeic acid; LDL oxidation; Men; Phenolic acids; Protocatechuic acid; Uric acid; Wine

Indexed keywords

CAFFEIC ACID; GALLIC ACID DERIVATIVE; LIPOPROTEIN; PHENOL DERIVATIVE; PROTOCATECHUIC ACID; URIC ACID;

ADULT; ALCOHOL CONSUMPTION; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY RISK; HUMAN; ISCHEMIC HEART DISEASE; LIPID OXIDATION; MALE; NUTRITIONAL VALUE; WINE;

EID: 0033962527     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/71.1.67     Document Type: Article

References (39)

1. St Leger AS, Cochrane AL, Moore F. Factors associated with cardiac mortality in developed countries with particular reference to the consumption of wine. Lancet 1979;1:1017-20.
2. Rimm EB, Klatsky A, Grobbee D, Stampfer MJ. Review of moderate alcohol consumption and reduced risk of coronary heart disease: is the effect due to beer, wine or spirits? BMJ 1996;312:731-6.
3. Abu-Amsha R, Croft KD, Puddey IB, Proudfoot JM, Beilin LJ. Phenolic content of various beverages determines the extent of inhibition of human serum and low-density lipoprotein oxidation in vitro: identification and mechanism of action of some cinnamic acid derivatives from red wine. Clin Sci 1996;91:449-58.
4. Frankel EN, Kanner J, German JB, Parks E, Kinsella JE. Inhibition of oxidation of human low density lipoprotein by phenolic substances in red wine. Lancet 1993;341:454-7.
5. Meyer AS, Yi O-S, Pearson DA, Waterhouse AL, Frankel EN. Inhibition of human low-density lipoprotein oxidation in relation to composition of phenolic antioxidants in grapes (Vitis vinifera). J Agric Food Chem 1997;45:1638-43.
6. Witztum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 1991;88:1785-92.
7. Fuhrman B, Lavy A, Aviram M. Consumption of red wine with meals reduces the susceptibility of human plasm and low-density lipoprotein to lipid peroxidation. Am J Clin Nutr 1995;61:549-54.
8. de Rijke YB, Demacker PNM, Assen NA, Sloots LM, Katan MB, Stalenhoef AFH. Red wine consumption does not affect oxidizability of low-density lipoproteins in volunteers. Am J Clin Nutr 1996;63:329-34.
9. Carbonneau M-A, Leger CL, Monnier L, et al. Supplementation with wine phenolic compounds increases the antioxidant capacity of plasma and vitamin E of low-density lipoprotein without changing the lipoprotein Cu-oxidizability: possible explanation by phenolic location. Eur J Clin Nutr 1997;51:682-90.
10. Day AP, Kemp HJ, Bolton C, Hartog M, Stansbie D. Effect of concentrated red grape juice consumption on serum antioxidant capacity and low-density lipoprotein oxidation. Ann Nutr Metab 1997;41:353-7.
11. Miyagi Y, Miwa K, Inoue H. Inhibition of human low-density lipoprotein oxidation by flavonoids in red wine and grape juice. Am J Cardiol 1997;80:1627-31.
12. Nigdikar SV, Williams NR, Griffin BA, Howard AN. Consumption of red wine polyphenols reduces the susceptibility of low-density lipoproteins to oxidation in vivo. Am J Clin Nutr 1998;68: 258-65.
13. Hollman PC, Katan MB. Absorption, metabolism and health effects of dietary flavonoids in man. Biomed Pharmacother 1997;51:305-10.
14. Jacobson EA, Newmark H, Baptista J, Bruce WR. A preliminary investigation of the metabolism of dietary phenolics in humans. Nutr Rep Int 1983;28:1409-17.
15. Bourne LC, Rice-Evans CA. Urinary detection of hydroxycinnamates and flavonoids in humans after high dietary intake of fruit. Free Radic Res Commun 1998;28:429-38.
16. Croft KD, Proudfoot J, Moulton C, Beilin LJ. The effect of lipoproteins on the release of some eicosanoids by stimulated leukocytes: a possible role in atherogenesis. Eicosanoids 1991;4:75-81.
17. Regnström J, Ström K, Moldeus P, Nilsson J. Analysis of lipoprotein diene formation in human serum exposed to copper. Free Radic Res Commun 1993;19:267-78.
18. Proudfoot JM, Puddey IB, Beilin LJ, Stocker R, Croft KD. Unexpected dose response of copper concentration on lipoprotein oxidation in serum: discovery of a unique peroxidase-like activity of urate/albumin in the presence of high copper concentrations. Free Radic Biol Med 1997;23:699-705.
19. Helrick K. Official methods of analysis of the Association of Official Analytical Chemists. 15th ed. Arlington, VA: AOAC, 1990:703.
20. Schultz M, Leist M, Petrzika M, Gassmann B, Brigelius-Flohe R. Novel urinary metabolite of a-tocopherol, 2,5,7,8-tetramethyl-2(2′-carboxyethyl)-6-hydroxychroman, as an indicator of an adequate vitamin E supply? Am J Clin Nutr 1995;62(suppl): 1527S-34S.
21. Luz Cardona M, Fernandez I, Begona Garcia M, Pedro JR. Synthesis of natural polyhydroxystilbenes. Tetrahedron 1986;42: 2725-30.
22. Burch RE, Kurke N. The effect of lactate infusion on serum uric acid. Proc Soc Exp Biol Med 1968;127:17-20.
23. Shahrzad S, Bitsch I. Determination of gallic acid and its metabolites in human plasma and urine by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 1998;705:87-95.
24. Waterhouse AL, German JB, Walzem RL, Hansen RJ, Kasim-Karakas SE. Is it time for a wine trial? Am J Clin Nutr 1998;68:220-1.
25. Serafini M, Maiani G, Ferro-Luzzi A. Alcohol-free red wine enhances plasma antioxidant capacity in humans. J Nutr 1998;128:1003-7.
26. Paganga G, Rice-Evans CA. The identification of flavonoids as glycosides in human plasma. FEBS Lett 1997;401:78-82.
27. Hollman PCH, van Trijp JMP, Buysman MNCP, et al. Relative bioavailability of the antioxidant flavonoid quercetin from various foods in man. FEBS Lett 1997;418:152-6.
28. Smith EL, Hill RL, Lehman IR, Lefkowitz RJ, Handler P, White A, eds. Principles of biochemistry: mammalian biochemistry. New York: McGraw-Hill Book Company, 1983.
29. Hollman PCH. Bioavailability of flavonoids. Eur J Clin Nutr 1997;51:866-9.
30. 14C]catechin in man following oral administration. Xenobiotica 1985;15:907-14.
31. Day A, Stansbie D. Cardioprotective effect of red wine may be mediated by urate. Clin Chem 1995;41:1319-20.
32. Maxwell S, Cruickshank A, Thorpe G. Red wine and antioxidant activity of serum. Lancet 1994;344:193-4.
33. Whitehead PT, Robinson D, Allaway S, Syms J, Hale A. Effect of red wine ingestion on the antioxidant capacity of serum. Clin Chem 1995;41:32-5.
34. Morrow JD, Roberts LJ. The isoprostanes: current knowledge and directions for future research. Biochem Pharmacol 1996;51:1-19.
35. 2-isoprostanes) in smokers. N Engl J Med 1995;332:1198-203.
36. Puddey IB, Croft K. Alcoholic beverages and lipid peroxidation: relevance to cardiovascular disease. Addict Biol 1997;2:269-76.
37. Mufti SI, Eskelson CD, Odeleye OE, Nachiappan V. Alcohol-associated generation of oxygen free radicals and tumor promotion. Alcohol Alcohol 1993;28:621-38.
38. Bjørneboe A, Bjørneboe G-E. Antioxidant status and alcohol-related diseases. Alcohol Alcohol 1993;28:111-6.
39. Lecomte E, Herbeth B, Pirollet P, et al. Effect of alcohol consumption on blood antioxidant nutrients and oxidative stress indicators. Am J Clin Nutr 1994;60:255-61.